斯堪的纳维亚移位性锁骨外侧骨折试验(ScanDiLaC):一项随机临床试验的研究方案
针对移位性锁骨外侧关节外骨折治疗证据不足的问题,本试验为实用性、非劣效、允许患者偏好的多中心随机对照试验,计划纳入100例18–65岁患者,按1:1随机分配至手术或非手术治疗,主要结局为1年时DASH评分。
要点
- 比较移位性锁骨外侧骨折手术与非手术治疗的疗效。
- 主要结局为1年时DASH评分,非劣效设计。
- 允许6周后早期交叉,并设观察性队列纳入不愿随机者。
核心结论
- 该随机对照试验旨在比较移位性锁骨外侧骨折手术与非手术治疗的结局,可能为临床决策提供依据。
研究设计与样本
- 实用性、非劣效、允许患者偏好的多中心随机对照试验,计划纳入100例18至65岁移位性锁骨外侧骨折患者。
- 按1:1比例随机分配至手术或非手术治疗,允许6周后早期交叉,另设观察性队列纳入不愿随机者。
- 涉及瑞典、挪威、丹麦和芬兰的多家医院。
关键数值与推荐
- 主要结局为1年时DASH评分。
- 随访时间点为6周、3个月、6个月和1年。
- 次要结局包括DASH评分、EQ-5D-5L评分、UCLA活动评分、诺丁汉锁骨评分(NCS)、疼痛视觉模拟量表(VAS)和患者整体印象变化(PGIC)锚定问题。
- 报告所有并发症、影像学愈合和重返工作。
临床怎么用
- 该试验结果可能帮助理解手术与非手术治疗移位性Neer II型和V型锁骨外侧骨折的结局差异,并指导治疗流程制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence regarding the treatment of displaced, extraarticular lateral clavicle fractures is scarce. No study has shown clinically significant differences between surgical and nonsurgical treatment, but the sample sizes have been small, as it has been difficult to include enough patients with this relatively uncommon fracture type. PURPOSE: This study aims to compare outcomes after surgical and nonsurgical treatment for displaced lateral clavicle fractures. METHODS: This is a pragmatic, noninferiority, preference-tolerant, randomized controlled trial (RCT). A total of 100 patients between the ages of 18 and 65 with displaced lateral clavicle fractures will be randomly allocated on a 1:1 ratio to surgical or nonsurgical treatment with the option of early crossover after 6 weeks. An observational cohort will comprise patients not willing to be randomized. This is a multicenter Scandinavian RCT including hospitals in Sweden, Norway, Denmark, and Finland. The primary outcome is the Disabilities of the Arm, Shoulder and Hand (DASH) score at 1 year. Follow-up points will be 6 weeks, 3 months, 6 months, and 1 year. The secondary outcomes are the DASH score, the EQ-5D-5L score, the University of California, Los Angeles (UCLA) activity score, the Nottingham Clavicle Score (NCS), a visual analog scale (VAS) for pain, and anchor questions in the form of the Patient Global Impression of Change (PGIC) collected at all timepoints during the study. All complications, radiographic healing, and return to work will be reported. DISCUSSION: The optimal treatment for displaced Neer type II and V lateral clavicle fractures remains a topic of debate. This RCT may provide a better understanding of the differences in outcomes of nonsurgical and surgical treatment while reflecting real-world clinical practice and guiding the development of a treatment algorithm for the orthopedic community. TRIAL REGISTRATION: ClinicalTrials.gov NCT06981065. Registered on 19 May 2025. https://clinicaltrials.gov/study/NCT06981065?term=Scandilac&rank=1.
引用
- Christersson P, Karimi D, Grønhaug K, et al. The Scandinavian Displaced Lateral Clavicle trial (ScanDiLaC): a study protocol for a randomized clinical trial. Trials. 2026. PMID: 42288927. doi:10.1186/s13063-026-09844-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。